A High Lp(a) with an Otherwise Normal Panel
Lp(a) is set almost entirely by the genes you were born with. It barely moves with diet, exercise or statins, it carries cardiovascular risk independently of everything else on the panel, and it needs measuring only once in a lifetime. It is also absent from most routine lipid panels, which means a great many people have never had the most fixed part of their risk looked at.
The pattern on your report
- Lp(a) High · marked Key
- LDL Normal Key
- HDL Normal Key
- Triglycerides Normal Key
Printed as: HDL in mmol/Lor mg/dLLDL in mmol/Lor mg/dLLp(a) in nmol/Lor mg/dL— The two units measure different things, particle concentration against mass, and no single conversion is reliable because particle size varies between people. Compare only against the range from the laboratory that ran it.Triglycerides in mmol/Lor mg/dL
Why the numbers look like this
An Lp(a) particle is an LDL particle with an extra protein, apolipoprotein(a), attached. That protein resembles plasminogen, which is part of the machinery that dissolves clots, and the resemblance is thought to let Lp(a) interfere with clot breakdown while also depositing cholesterol in artery walls in the ordinary way.
How much you make is determined largely by one gene, and the level you have at twenty is broadly the level you will have at sixty. Diet moves it very little. Statins do not lower it and may raise it slightly. That makes it different in kind from everything else on a lipid panel: a fixed inherited exposure, not something you are managing.
Which is also why it needs measuring once and not repeatedly.
Not being flagged is not the same as normal
Two reporting units are in use and they are not interchangeable. Some laboratories report mass in mg/dL, others report particle concentration in nmol/L, and there is no single reliable conversion between them because Lp(a) particles vary in size. A result should be compared against the range printed by the laboratory that produced it. Whichever unit is used, the risk relationship is continuous: higher means more risk, without a threshold at which it begins.
What else on the report can hide this
Knowing matters because of what it changes elsewhere. A raised Lp(a) does not have a treatment of its own in routine practice, but it raises overall risk, and the accepted response is to treat every modifiable factor more determinedly: LDL or ApoB lowered further, blood pressure controlled tighter, smoking stopped.
It runs strongly in families, so a raised result is information about your first-degree relatives as much as about you, and testing siblings and children is reasonable. Drugs designed to lower Lp(a) directly are in late-stage trials, which is one more reason knowing the level is worth something even now.
One technical point worth knowing. Because Lp(a) contains cholesterol, part of your measured LDL is actually Lp(a) cholesterol. In someone with a very high Lp(a), the LDL that appears resistant to treatment may be partly this, which explains a treatment failure that is not one.
What usually causes it
Listed from most to least common — not from most to least serious.
- Very common
Inherited
Almost the whole explanation. Determined largely by one gene, stable through life, and unaffected by the things that move the rest of the panel.
- Very common
Ancestry-related variation — in populations differ substantially
Average levels differ between ancestral groups, with people of African ancestry tending to run higher. How that maps onto risk is still being worked out, which is a reason for caution rather than dismissal.
- Common
Chronic kidney disease
One of the few acquired states that raises Lp(a) meaningfully, particularly nephrotic syndrome.
- Uncommon
Hypothyroidism
Raises it modestly, and treating the thyroid brings it back down. Worth excluding once.
- Uncommon
The menopause — in the menopausal transition
Levels rise across the transition, alongside the LDL rise that happens at the same time.
- Uncommon
Acute inflammation
Lp(a) behaves partly as an acute-phase protein, so a result taken during illness can read high. Repeat when well before treating it as your baseline.
What is usually checked next
- Nothing, if the level is established and you are well Lp(a) is measured once. Repeating it is one of the few genuinely unnecessary tests in this field, unless the first was taken during illness.
- A full cardiovascular risk assessment Turns the finding into a plan, since the response is to treat the modifiable factors harder rather than to treat Lp(a) itself.
- ApoB or non-HDL cholesterol Gives a target that can actually be moved, and is what treatment intensity is judged against.
- Testing first-degree relatives The inheritance is dominant, so siblings and children have a substantial chance of the same level and the same unrecognized risk.
- TSH Excludes the one common treatable contributor before the value is accepted as your fixed baseline.
When to seek care sooner
- Emergency Sudden weakness on one side, slurred speech, or loss of vision
- Same day Chest pain or tightness on exertion
- Soon A close relative who had a heart attack or stroke before 60
- Soon Pain in the calves when walking that eases with rest
- Soon New breathlessness on exertion
Questions worth bringing to your appointment
- Was my Lp(a) reported in mg/dL or nmol/L, and what is the range for that assay?
- Given this result, should my LDL or ApoB target be lower than it would otherwise be?
- Should my siblings and children be tested?
- Does this need repeating, or is once enough?
- Was I unwell when the sample was taken?